Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder.

Vagus nerve stimulation (VNS) shows a positive treatment effect and improved quality of life (QoL) among patients with ...

Medically reviewed by Dakari Quimby, PhD Male postpartum depression describes when a new father experiences postpartum ...

A single dose of psilocybin may offer relief for patients with severe treatment-resistant depression, according to an open-label study published in the American Journal of Psychiatry. The research, ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Stimulating either of a pair of crucial nerves that carry messages from the brain to several major organs could be an ...